Transcriptional control of oligodendrocyte differentiation and myelination

少突胶质细胞是在中枢神经系统的所有区域中发现的髓鞘形成神经胶质细胞。 神经系统少突胶质细胞的主要功能是形成髓鞘 以确保电信号的快速和忠实的传输。 在发育过程中，少突胶质细胞前体细胞（OPCs）必须经历一个 一系列形态和分子的变化， 分化为成熟的髓鞘少突胶质细胞。分化和 少突胶质细胞的髓鞘形成过程受到转录的严格控制 因素最近的研究表明，Sox10转录因子直接与 OPC刺激分化和髓磷脂基因表达。然而，OPC 分化受到其他转录因子（TF）的严格调控，包括 Nkx2.2、Olig1、Hes5和Id4，它们都在未分化的OPC细胞中表达 中枢神经系统的发育。虽然Nkx2.2和Olig1的功能是 促进OPC分化，Hes 5和Id4作为OPC成熟的抑制剂。的 这四种调节性TF在控制OL中的功能关系 差异尚未确定。在本申请中，我们假设， Nkx2.2通过抑制OPC的表达或功能间接促进OPC成熟 Hes 5和Id4的，但与Olig1协同作用，促进OPC 分化这些假设将在提案的前两个目标中得到检验。 最近的数据显示，Nkx2.2在分化的OL中快速下调， Nkx2.2在少突胶质细胞系中的过表达抑制MBP基因表达， 增加了Nkx2.2转变其作用成为髓磷脂阻遏物的可能性 在成熟OL中的基因表达，以防止过量的髓鞘产生。这 将在提案的第三个目标中审查这种可能性。最后，我们将测试 假设Sox 10在成熟OL中持续表达功能是维持 髓鞘基因表达和髓鞘稳定性。Sox 10和 髓鞘形成OL细胞中的Nkx2.2可能负责髓鞘的微妙平衡 生产和结构维护。 这项研究可以帮助我们了解控制 轴突髓鞘形成过程，并提供深入了解分子的发展， 刺激少突胶质细胞再生和髓鞘再生的方法 脱髓鞘疾病

Oligodendrocytes are myelinating glial cells found in all regions of the central nervous system. The major function of oligodendrocytes is to form myelin sheaths around axons to ensure the rapid and faithful transmission of electrical signals. During development, oligodendrocytes precursor cells (OPCs) have to go through a series of morphological and molecular changes before they become fully differentiated into mature myelinating oligodendrocytes. The differentiation and myelination processes of oligodendrocytes are tightly controlled by transcription factors. Recent studies have demonstrated that Sox10 transcription factor directly stimulates OPC differentiation and myelin gene expression. However, OPC differentiation is tightly regulated by other transcription factors (TFs) including Nkx2.2, Olig1, Hes5 and Id4, all of which are expressed in undifferentiated OPC cells in the developing central nervous system. While Nkx2.2 and Olig1 function to promote OPC differentiation, Hes5 and Id4 act as inhibitors of OPC maturation. The functional relationship of these four regulatory TFs in the control of OL differentiation has not been determined. In this application, we hypothesize that Nkx2.2 enhances OPC maturation indirectly by suppressing the expression or function of Hes5 and Id4, but functions synergistically with Olig1 in promoting OPC differentiation. These hypotheses will be tested in the first two aims of the proposal. Recent data showed that Nkx2.2 is rapidly down-regulated in differentiated OLs and over-expression of Nkx2.2 in oligodendrocyte cell line inhibits MBP gene expression, raising the possibility that Nkx2.2 switches its role to become a repressor of myelin gene expression in mature OLs to prevent excessive myelin production. This possibility will be examined in the third aim of the proposal. Finally, we will test the hypothesis that persistent expression of Sox10 in mature OLs functions to maintain myelin gene expression and myelin sheath stability. The interplay of Sox10 and Nkx2.2 in myelinating OL cells may be responsible for the delicate balance of myelin production and structural maintenance. This line of study could help us understand molecular pathways that control axonal myelination process and provide insights into the development of molecular approaches to stimulate oligodendrocyte regeneration and remyelination in demyelinating diseases.